Larvol Delta - ABL-Bio-said-it-is-launching-a-global-Phase-3-clinical-trial-of-its-gastric-cancer-candidate-givastomig-ABL111-within-this-year-and-plans-to-start-the-study-in-December-2026

givastomig (TJ-CD4B) - NovaBridge Biosciences, ABL Bio

https://www.mk.co.kr/en/it/12083258

Jun 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next